Pfizer Covid vaccine cuts Omicron hospitalisations by 70% in real-world study1 min read . Updated: 14 Dec 2021, 04:32 PM IST
- The study was based on more than 211,000 positive Covid test results from 15 November to 7 December , around 78,000 of which were attributed to Omicron.
Two doses of Pfizer-BioNTech's Covid-19 vaccine appear to have given 70% protection against hospitalisation in South Africa in recent weeks, a major real-world study on the potential impact of Omicron showed on Tuesday, as the country battles a spike in infections linked to the new variant.
Select your Category